文献速递精神分裂症与精神病性障碍心境障碍

精神分裂样与情感障碍患者脑脊液新型抗中枢神经系统自身抗体谱

Spectrum of Novel Anti-Central Nervous System Autoantibodies in the Cerebrospinal Fluid of 119 Patients With Schizophreniform and Affective Disorders.
PubMed 文献 · Biol Psychiatry · 2022-02-19

该研究对119例精神分裂样和情感综合征患者的血清和脑脊液进行基于组织的间接免疫荧光检测,发现18%(n=22)患者存在抗中枢神经系统IgG自身抗体,脑脊液阳性率(18%)高于血清(9%),呈现五种主要结合模式。新型自身抗体阳性患者较阴性者更常见白蛋白商升高(p=.026)和白质改变(p=.020)。

要点

  • 119例精神分裂样和情感综合征患者中18%检出抗中枢神经系统IgG自身抗体,脑脊液阳性率高于血清。
  • 自身抗体呈现五种主要结合模式:血管结构、小脑和海马颗粒细胞、髓鞘化纤维、小脑浦肯野细胞和星形胶质细胞。
  • 新型自身抗体阳性患者较阴性者更常见白蛋白商升高(p=.026)和白质改变(p=.020)。

核心结论

  • 该研究在精神分裂样和情感综合征患者脑组织上展示了五种新型自身抗体结合模式,脑脊液较血清更常呈阳性,这些患者群体中自身抗体的频率和谱系可能比既往认为的更广泛。

研究设计与样本

  • 对119例精神分裂样和情感综合征患者的血清和脑脊液进行分析,采用基于组织的间接免疫荧光法检测IgG抗中枢神经系统自身抗体,使用未固定小鼠脑组织。
  • 初始评估有自身免疫性精神病警示信号的患者(n=30)后,将基于组织的检测扩展为常规程序(n=89)。

主要发现

  • 全部119例患者中,18%(n=22)检出针对脑组织的抗中枢神经系统IgG自身抗体(血清9%,脑脊液18%)。
  • 五种主要结合模式:抗血管结构(可能为内皮细胞)(血清3%,脑脊液8%);抗小脑和/或海马颗粒细胞(血清4%,脑脊液6%);抗髓鞘化纤维(血清2%,脑脊液2%);抗小脑浦肯野细胞(血清0%,脑脊液2%);抗星形胶质细胞(血清1%,脑脊液1%)。
  • 新型抗中枢神经系统自身抗体阳性患者较自身抗体阴性者更常见白蛋白商升高(p=.026)和白质改变(p=.020)。

关键数值与推荐

  • 抗中枢神经系统IgG自身抗体总检出率18%(n=22),血清9%,脑脊液18%。
  • 抗血管结构(可能为内皮细胞)抗体:血清3%,脑脊液8%;抗小脑和/或海马颗粒细胞抗体:血清4%,脑脊液6%;抗髓鞘化纤维抗体:血清2%,脑脊液2%;抗小脑浦肯野细胞抗体:血清0%,脑脊液2%;抗星形胶质细胞抗体:血清1%,脑脊液1%。
  • 自身抗体阳性者较阴性者白蛋白商升高更常见(p=.026),白质改变更常见(p=.020)。

临床怎么用

  • 在精神分裂样和情感综合征患者的临床常规中,可采用基于组织的间接免疫荧光法检测血清和脑脊液抗中枢神经系统自身抗体。
  • 脑脊液检测较血清更常呈阳性,结果解读时应考虑检测基质和样本来源。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Autoimmune psychosis may be caused by well-characterized anti-neuronal autoantibodies, such as those against the NMDA receptor. However, the presence of additional anti-central nervous system (CNS) autoantibodies in these patients has not been systematically assessed. METHODS: Serum and cerebrospinal fluid (CSF) from patients with schizophreniform and affective syndromes were analyzed for immunoglobulin G anti-CNS autoantibodies using tissue-based assays with indirect immunofluorescence on unfixed murine brain tissue as part of an extended routine clinical practice. After an initial assessment of patients with red flags for autoimmune psychosis (n = 30), tissue-based testing was extended to a routine procedure (n = 89). RESULTS: Based on the findings from all 119 patients, anti-CNS immunoglobulin G autoantibodies against brain tissue were detected in 18% (n = 22) of patients (serum 9%, CSF 18%) following five principal patterns: 1) against vascular structures, most likely endothelial cells (serum 3%, CSF 8%); 2) against granule cells in the cerebellum and/or hippocampus (serum 4%, CSF 6%); 3) against myelinated fibers (serum 2%, CSF 2%); 4) against cerebellar Purkinje cells (serum 0%, CSF 2%); and 5) against astrocytes (serum 1%, CSF 1%). The patients with novel anti-CNS autoantibodies showed increased albumin quotients (p = .026) and white matter changes (p = .020) more frequently than those who tested negative for autoantibodies. CONCLUSIONS: The study demonstrates five novel autoantibody-binding patterns on brain tissue of patients with schizophreniform and affective syndromes. CSF yielded positive findings more frequently than serum analysis. The frequency and spectrum of autoantibodies in these patient groups may be broader than previously thought.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Endres D, von Zedtwitz K, Matteit I, et al. Spectrum of Novel Anti-Central Nervous System Autoantibodies in the Cerebrospinal Fluid of 119 Patients With Schizophreniform and Affective Disorders. Biol Psychiatry. 2022. PMID: 35606187. doi:10.1016/j.biopsych.2022.02.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。